| For: | Khandpur S, Mishra P, Mishra S, Tiwari S. Challenges in predictive modelling of chronic kidney disease: A narrative review. World J Nephrol 2024; 13(3): 97214 [PMID: 39351189 DOI: 10.5527/wjn.v13.i3.97214] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v13/i3/97214.htm |
| Number | Citing Articles |
| 1 |
Bing Zhang, Liufei Deng. Application of SGLT-2 inhibitors in non-diabetic CKD: mechanisms, efficacy, and safety. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1574693
|
| 2 |
Yan-ni Wang, Xin Wu, Qi-yan Shan, Qiao Yang, Xiao-yong Yu, Jian-hua Yang, Hua Miao, Gang Cao, Ying-yong Zhao. Acteoside-containing caffeic acid is bioactive functional group of antifibrotic effect by suppressing inflammation via inhibiting AHR nuclear translocation in chronic kidney disease. Acta Pharmacologica Sinica 2025; 46(11): 2975 doi: 10.1038/s41401-025-01598-4
|
| 3 |
Tingting Yuan, Hong Wang, Ting Kang, Weihua Wu, Santao Ou. Advancements in the non-invasive diagnosis of renal fibrosis. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1646412
|
| 4 |
Chen-Hui Jiang, Shui-Juan Zhang, Ping Li, Hua Miao, Ying-Yong Zhao. Natural products targeting TGF-β/Smad signaling in renal fibrosis: Multiomics-based novel molecular mechanisms and therapeutic strategies. Phytomedicine 2025; 148: 157496 doi: 10.1016/j.phymed.2025.157496
|
| 5 |
Jiawei Zhang, Xiangge Ren, Bing Li, Zhifen Zhao, Shoudao Li, Wensheng Zhai. Fecal microbiota transplantation is a promising therapy for kidney diseases. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1628722
|
| 6 |
Xingfu Ji, Guilin Jing, Haoqi Sun, Xuan Li, Xuexun Chen. Case report and literature review: IgG4-related tubulointerstitial nephritis coexistent with systemic lupus erythematosus. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1585351
|
| 7 |
Weiwei Li, Lumiao Chen, Linsen Jiang, Zhijian Zhang, Kai Song. The prognostic nutritional index as a predictor of cardiovascular and all-cause mortality in chronic kidney disease: a population-based analysis of NHANES data (1999–2018). Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1589173
|
| 8 |
Haojie Liu, Xiadan Xiang, Chengqian Shi, Jiaowei Guo, Ting Ran, Jinglian Lin, Futing Dong, Jie Yang, Hua Miao. Oxidative stress and inflammation in renal fibrosis: Novel molecular mechanisms and therapeutic targets. Chemico-Biological Interactions 2025; 421: 111784 doi: 10.1016/j.cbi.2025.111784
|
| 9 |
Hua Miao, Kai-En Wang, Ping Li, Ying-Yong Zhao. Rhubarb: Traditional Uses, Phytochemistry, Multiomics-Based Novel Pharmacological and Toxicological Mechanisms. Drug Design, Development and Therapy 2025; : 9457 doi: 10.2147/DDDT.S557114
|
| 10 |
Yumeng Li, Yousuf Waheed, Dong Sun. Exosomes and Renal Fibrosis: Diagnostic Value, Therapeutic Potential and Challenges. International Journal of Nanomedicine 2025; : 11267 doi: 10.2147/IJN.S529311
|
| 11 |
Hao-Yu Feng, Yi-Qi Wang, Jianhua Yang, Hua Miao, Ying-Yong Zhao, Xiaojuan Li. Anthraquinones from Rheum officinale Ameliorate Renal Fibrosis in Acute Kidney Injury and Chronic Kidney Disease. Drug Design, Development and Therapy 2025; : 5739 doi: 10.2147/DDDT.S521265
|
| 12 |
Lianxiang Duan, Ziyang Liu, Ling Chen, Yiqing Yang, Yenan Fan, Jie Chen, Jing Hu, Xuezhong Gong, Yue Guo. Efficacy and safety of Guben Tongluo formula in treating chronic kidney disease (stage G3): a multicenter randomized controlled clinical trial. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1691637
|
